Pittsburgh compound-b
- 0 on aging of 5 trials, 3 with no results posted
Trials
0 on aging of 5In trials
Phase 4Enrolling by invitation2 trials
Phase 4Enrolling by invitation2 trials
Phase 4Enrolling by invitation1 trial
Phase 4Enrolling by invitation1 trial
Phase 4Enrolling by invitation1 trial
Phase 1Completed2 trials
All 8Fewer
Primary progressive aphasia
Phase 1Completed1 trial
Early phase 1Completed1 trial
Trial sponsors
Company1 trialPhase 135 people
2 trialsPhase 1195 people
1 trialEarly phase 139 people
Latest
4 in 12 monthsJournal of Alzheimer's Disease
Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults
Cohort study of 1,039 peopleTau
Journal of the American Geriatrics Society
Driving Navigation in Older Adults Across the Alzheimer's Disease Continuum
Cohort study in peopleAlzheimer's disease
Journal of Alzheimer's Disease
Depression modifies age-associated [¹¹C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease
Study in peoplePopulations
Annals of Neurology
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
Cohort study of 241 peopleAlzheimer's disease